(NASDAQ:ADN), LIVERMORE, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) — Advent Technologies Holdings, Inc. (NASDAQ: ADN), an innovation-driven leader in fuel cell and hydrogen technology, is accelerating the electrification of aviation through its cutting-edge high-temperature proton exchange membrane fuel cells (HT-PEM FCs). In collaboration with Stralis Aircraft and other aerospace pioneers, Advent's technology is helping enable […]

(NasdaqGM:USAR),(NasdaqGM:USARW), STILLWATER, Okla., Oct. 29, 2025 (GLOBE NEWSWIRE) — USA Rare Earth (Nasdaq: USAR) (USAR or the Company) today announced the appointment of Alex Moyes, PhD, as Vice President of Mining. In this role, Dr. Moyes will lead USAR's mining operations and drive the continued development and extraction planning for the Company's deposit in Round

(TSX-V:XRTX),(NASDAQ:XRTX),(Boerse Frankfurt – Freiverkehr:ANUA.F), CALGARY, Alberta, Oct. 29, 2025 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company“) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, announces that it has closed its registered direct offering announced on

Company reports record third quarter revenue and operating income, and raises full year EPS guidance Garmin® Ltd. (NYSE: GRMN), today announced results for the third quarter ended September 27, 2025. https://mma.prnewswire.com/media/1914892/Garmin_Logo.jpg Highlights for third quarter 2025 include: — Record consolidated revenue of approximately $1.8 billion, a 12% increase compared to the prior year quarter —

(NasdaqGM:PLBY), LOS ANGELES, Oct. 29, 2025 (GLOBE NEWSWIRE) — Playboy, Inc. (NASDAQ: PLBY) (the “Company” or “Playboy”), a leading pleasure and leisure lifestyle company, and one of the most recognizable and iconic brands in the world, today announced that it will release its financial results for its third quarter of 2025 on Wednesday, November 12,

(NASDAQ:BBIO), – The CALIBRATE study of encaleret for patients with ADH1 met all pre-specified primary and key secondary efficacy endpoints – The primary endpoint was met with 76% of participants administered encaleret achieving both serum and urine calcium within the respective target ranges at Week 24 compared to 4% when on conventional therapy at Week

(NASDAQ:BYND), EL SEGUNDO, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) — Beyond Meat, Inc. (NASDAQ: BYND) (the “Company” or “Beyond Meat”), a leader in plant-based meat, today announced the final tender results of its previously announced exchange offer (the “Exchange Offer”) to exchange any and all of its 0% Convertible Senior Notes due 2027 (the “Existing

(NASDAQ:COCO), Net Sales Increased 37% to $182 million driven by Vita Coco Coconut Water growth of 42% Net Income Increased $5 million to $24 million and Non-GAAP Adjusted EBITDA1 Increased $9 million to $32 million Company Raises Full Year Net Sales and Adjusted EBITDA Guidance NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) — The Vita

(NasdaqGM:ORKA), MENLO PARK, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) — Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical stage biotechnology company developing novel biologics designed to set a new standard for the treatment of chronic skin diseases including plaque psoriasis, today announced presentations at the following upcoming investor conferences: Guggenheim 2nd Annual Healthcare Innovation ConferenceDate:

(NASDAQ:CCB), EVERETT, Wash., Oct. 29, 2025 (GLOBE NEWSWIRE) — Coastal Financial Corporation (Nasdaq: CCB) (the “Company”, “Coastal”, “we”, “our”, or “us”), the holding company for Coastal Community Bank (the “Bank”), through which it operates a community-focused bank segment (“community bank”) with an industry leading banking as a service (“BaaS”) segment (“CCBX”), today reported unaudited financial